| Product Code: ETC328901 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The immunology market in Qatar is experiencing significant growth, propelled by a rising incidence of autoimmune disorders and an increased focus on advanced healthcare solutions. Immunology encompasses a wide range of therapeutic areas, including rheumatology, dermatology, and gastroenterology, among others. With a growing awareness about the benefits of immunomodulatory therapies, there is an expanding market for biologics and targeted immunotherapies. Qatar`s robust healthcare infrastructure and a well-established research ecosystem further position the country as a hub for advancements in immunological treatments.
The Qatar immunology market is expected to expand due to increasing investments in healthcare infrastructure and research. Advancements in immunology treatments, along with a growing aging population, will drive demand for immunology-related therapies and diagnostics.
The immunology market in Qatar faces challenges related to access to advanced therapies and the adoption of innovative treatments. Keeping pace with the rapid advancements in immunology and immunotherapy can be a hurdle for healthcare providers and patients. Balancing the cost of cutting-edge treatments with the need to provide accessible healthcare for the population is a significant challenge for the immunology sector in Qatar.
The field of immunology in Qatar has gained prominence due to the COVID-19 pandemic. Research and development efforts in immunology have been accelerated to better understand the virus and develop effective treatments and vaccines. The pandemic has also highlighted the importance of immunology in public health, leading to increased investments in research, diagnostics, and therapies in this field.
The immunology market in Qatar is witnessing significant growth due to the rising incidence of autoimmune diseases and the increasing focus on advanced biologic therapies. Key players in this sector include global pharmaceutical giants like AbbVie, Amgen, and Novartis, which provide a range of immunology treatments. Qatar`s healthcare system`s ongoing development and investment in cutting-edge therapies contribute to a positive outlook for the immunology market in the country.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Qatar Immunology Market Overview |
3.1 Qatar Country Macro Economic Indicators |
3.2 Qatar Immunology Market Revenues & Volume, 2021 & 2031F |
3.3 Qatar Immunology Market - Industry Life Cycle |
3.4 Qatar Immunology Market - Porter's Five Forces |
3.5 Qatar Immunology Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Qatar Immunology Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Qatar Immunology Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Qatar Immunology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases in Qatar |
4.2.2 Growing investments in healthcare infrastructure and research and development |
4.2.3 Rising awareness about immunology and related treatments in the region |
4.3 Market Restraints |
4.3.1 High cost of immunology treatments and therapies |
4.3.2 Limited availability of skilled healthcare professionals specializing in immunology in Qatar |
5 Qatar Immunology Market Trends |
6 Qatar Immunology Market, By Types |
6.1 Qatar Immunology Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Qatar Immunology Market Revenues & Volume, By Drug Class, 2021-2031F |
6.1.3 Qatar Immunology Market Revenues & Volume, By Monoclonal Antibody (mAb), 2021-2031F |
6.1.4 Qatar Immunology Market Revenues & Volume, By Fusion Proteins, 2021-2031F |
6.1.5 Qatar Immunology Market Revenues & Volume, By Immunosuppressants, 2021-2031F |
6.1.6 Qatar Immunology Market Revenues & Volume, By Polyclonal Antibody (pAb), 2021-2031F |
6.1.7 Qatar Immunology Market Revenues & Volume, By Others, 2021-2031F |
6.2 Qatar Immunology Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Qatar Immunology Market Revenues & Volume, By Rheumatoid Arthritis, 2021-2031F |
6.2.3 Qatar Immunology Market Revenues & Volume, By Psoriatic Arthritis, 2021-2031F |
6.2.4 Qatar Immunology Market Revenues & Volume, By Plaque Psoriasis, 2021-2031F |
6.2.5 Qatar Immunology Market Revenues & Volume, By Ankylosing Spondylitis, 2021-2031F |
6.2.6 Qatar Immunology Market Revenues & Volume, By Inflammatory Bowel Disease, 2021-2031F |
6.2.7 Qatar Immunology Market Revenues & Volume, By Prophylaxis of Organ Rejection, 2021-2031F |
6.3 Qatar Immunology Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Qatar Immunology Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 Qatar Immunology Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.4 Qatar Immunology Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 Qatar Immunology Market Import-Export Trade Statistics |
7.1 Qatar Immunology Market Export to Major Countries |
7.2 Qatar Immunology Market Imports from Major Countries |
8 Qatar Immunology Market Key Performance Indicators |
8.1 Patient adherence rate to immunology treatments |
8.2 Number of clinical trials and research studies conducted in the field of immunology in Qatar |
8.3 Percentage of healthcare facilities offering specialized immunology services |
8.4 Rate of adoption of new immunology therapies and technologies in the market |
9 Qatar Immunology Market - Opportunity Assessment |
9.1 Qatar Immunology Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Qatar Immunology Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Qatar Immunology Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Qatar Immunology Market - Competitive Landscape |
10.1 Qatar Immunology Market Revenue Share, By Companies, 2024 |
10.2 Qatar Immunology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here